Diabetic Neuropathy
Diabetic neuropathy prevention may be obtained by understanding the pathological mechanisms
Published in Obesity and Diabetes Week, May 15th, 2006
According to a review from the United States, "Diabetic polyneuropathy (DPN) is the most common late diabetic complication, and is more frequent and severe in the type 1 diabetic population. Currently, no effective therapy exists to prevent or treat this complication."
A.A.F. Sima at Wayne State University recounted, "Hyperglycemia remains a major therapeutic target when dealing with DPN in both type 1 and type 2 diabetes, and should be supplemented by aldose reductase inhibition and antioxidant treatment. However, in the past few years, preclinical and clinical data...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Genetics & Genomics
Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity - Obesity & Cardiology
High leptin levels in obese may be beneficial to coronary endothelium - Obesity & Cardiology
PPAR-agonist improves left ventricular function in obese dyslipidemic mice - Obesity & Metabolic Syndrome
Obesity and leukocyte count link was dependent on the presence of metabolic syndrome - Obesity Pathogenesis
ENPP1, an insulin receptor inhibitor, is a genetic link between obesity and diabetes - Angiology
Endothelial cell progenitors display differential healing activities - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
